PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). So far, no substrates of PINK1 have been reported, and the mechanism by which PINK1 mutations lead to neurodegeneration is unknown. Here we report the identification of TNF receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 (Hsp75), as a cellular substrate for PINK1 kinase. PINK1 binds and colocalizes with TRAP1 in the mitochondria and phosphorylates TRAP1 both in vitro and in vivo. We show that PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria, and this protective action of PINK1 depends on its kinase activity to phosphorylate TRAP1. Moreover, we find that the ability of PINK1 to promote TRAP1 phosphorylation and cell survival is impaired by PD-linked PINK1 G309D, L347P, and W437X mutations. Our findings suggest a novel pathway by which PINK1 phosphorylates downstream effector TRAP1 to prevent oxidative-stress-induced apoptosis and implicate the dysregulation of this mitochondrial pathway in PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Phosphorylation of TRAP1 by Wild-Type and Mutant PINK1 (A) In vitro kinase assays were performed by incubation of purified TRAP1 with [γ32-P] ATP in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Phosphorylated TRAP1 was visualized by autoradiography (top panel). PINK1 and TRAP1 proteins used in the kinase assays were shown by immunoblotting with anti-TRAP1 (middle panel) and anti-FLAG antibodies (bottom panel). (B) Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. *Significantly different from the wild-type PINK1 (p < 0.01). (C) PC12 cells expressing wild-type or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 as indicated. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine (upper panel) and anti-TRAP1 (lower panel) antibodies. (D) Normalized levels of in vivo TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). AU, arbitrary units.](https://figures.cochat.ai/paper-figures/17d4ebdc4d0a46a99e4bb1385a64faa3/pink1-protects-against-oxidative-stress-by-phosphorylating-mitochondrial-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Normally, PINK1 serves a protective role by helping to produce the PTEN-induced kinase protein, which shields mitochondria from damage caused by the reactive oxygen species (ROS) [140].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911 · cited 1×
“Biochemical assays of cytochrome c release were performed as described [40].”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 2×
“served serine/threonine kinase domain [5].”
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · cited 1×
“Postmortem analyses reveal a deficiency in the mitochondrial complex I function in patients with sporadic PD [3].”
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 1×
“loss of PINK1 leads to mitochondrial defects and degeneration of muscle and dopaminergic neurons [”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“dopaminergic neurons [17–20].”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“In vitro kinase assays were performed as described [33] by incubation of affinity-purified FLAG-tagged wild-type or mutant PINK1 with TRAP1 for 20 min at 30 8C in 100 ll of reaction buffer containing 50 mM Tris-HCl (pH 7.”
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116 · cited 1×
“PC12 cells were treated with H2O2 as indicated, and cell viability was assessed using the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described [38].”
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024 · cited 1×
“of cellular processes, including cell survival and apoptosis [24, 25 ].”
Research works printed but not linked: 41
- Lang, 1998, N Engl J Med, 339, 1044
- Farrer, 2006, Nat Rev Genet, 7, 306
- Schapira, 1989, Lancet, 1, 1269
- Betarbet, 2002, Bioessays, 24, 308
- Valente, 2004, Science, 304, 1158
- Hatano, 2004, Ann Neurol, 56, 424
- Bonifati, 2005, Neurology, 65, 87
- Zadikoff, 2006, Mov Disord, 21, 875
- Hedrich, 2006, Arch Neurol, 63, 833
- Criscuolo, 2006, Mov Disord, 21, 1265
- Beilina, 2005, Proc Natl Acad Sci U S A, 102, 5703
- Silvestri, 2005, Hum Mol Genet, 14, 3477
- Gandhi, 2006, Brain, 129, 1720
- Nakajima, 2003, Cancer Lett, 201, 195
- Petit, 2005, J Biol Chem, 280, 34025
- Deng, 2005, Biochem Biophys Res Commun, 337, 1133
- Clark, 2006, Nature, 441, 1162
- Park, 2006, Nature, 441, 1157
- Wang, 2006, Proc Natl Acad Sci U S A, 103, 13520
- Yang, 2006, Proc Natl Acad Sci U S A, 103, 10793
- Song, 1995, J Biol Chem, 270, 3574
- Chen, 1996, Mol Cell Biol, 16, 4691
- Felts, 2000, J Biol Chem, 275, 3305
- Beere, 2005, J Clin Invest, 115, 2633
- Muchowski, 2005, Nat Rev Neurosci, 6, 11
- Masuda, 2004, J Biol Chem, 279, 42503
- Sim, 2006, Hum Mol Genet, 15, 3251
- Olzmann, 2004, J Biol Chem, 279, 8506
- Chin, 2000, J Biol Chem, 275, 1191
- Choi, 2004, J Biol Chem, 279, 13256
- Choi, 2006, J Biol Chem, 281, 10816
- Chin, 2001, J Biol Chem, 276, 7069
- Ninomiya-Tsuji, 1999, Nature, 398, 252
- Lewis Carl, 1993, J Histochem Cytochem, 41, 1273
- Li, 2002, J Biol Chem, 277, 28212
- Hovius, 1990, Biochim Biophys Acta, 1021, 217
- Kirk, 2006, J Cell Sci, 119, 4689
- Canet-Aviles, 2004, Proc Natl Acad Sci U S A, 101, 9103
- Chen, 2001, Proc Natl Acad Sci U S A, 98, 7783
- Yang, 1997, Science, 275, 1129
- Sherer, 2002, J Neurosci, 22, 7006
Cited by
Items 201–300 of 596
Nicoletti, V., Palermo, G., Prete, E. D., Mancuso, M., & Ceravolo, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.636506 · Cited by 81
Xiang, F., Huang, Y., Shi, X., & Zhang, Q. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07615.x · Cited by 74
O’Flanagan, C. H., Morais, V. A., Wurst, W., Strooper, B. D., & O’Neill, C. (2014) · Oncogene · doi:10.1038/onc.2014.81 · Cited by 78
Defective Autophagy in Parkinson’s Disease: Lessons from Genetics
Zhang, H., Duan, C., & Yang, H. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8787-5 · Cited by 79
“This finding suggests a novel pathway by which PINK1 phosphorylates downstream effector TRAP1 to prevent oxidative stress-induced apoptosis [75].”
BackgroundMitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration
Godoy, J. A., Ríos, J. A., Picón-Pagès, P., Herrera-Fernández, V., Swaby, B., Crepin, G., Vicente, R., Fernández‐Fernández, J. M., & Muñoz, F. J. (2021) · Biomolecules · doi:10.3390/biom11071012 · Cited by 76
“…Involved in interaction with mitochondrial proteins [349] TIM22 TDP-43 gains access to the mitochondrial matrix via the mitochondrial import inner membrane [350] CHCHD10 Involved in mitochondrial defects [337] Dbr1 suppresses TDP-43 toxicity [351] Ataxin 2 Increased risk for ALS [352] GSK-3 β…”
BackgroundParkinson's disease proteins: Novel mitochondrial targets for cardioprotection
Mukherjee, U., Ong, S., Ong, S., & Hausenloy, D. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.005 · Cited by 76
“PINK1 has been identified as a protective agent against oxidative stress-induced apoptosis—one of the mechanisms underlying this is through its phosphorylation of the mitochondrial chaperone TNF-receptor-associated protein 1, (TRAP1) (Pridgeon et al., 2007).”
BackgroundOnphachanh, X., Lee, H. J., Lim, J. R., Jung, Y. H., Kim, J. S., Chae, C. W., Lee, S., Gabr, A. A., & Han, H. J. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12427 · Cited by 72
The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
Trinh, D., Israwi, A. R., Arathoon, L. R., Gleave, J. A., & Nash, J. E. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15154 · Cited by 74
Deletion of the Mitochondrial Chaperone TRAP-1 Uncovers Global Reprogramming of Metabolic Networks
Lisanti, S., Tavecchio, M., Chae, Y. C., Liu, Q., Brice, A. K., Thakur, M. L., Languino, L. R., & Altieri, D. C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.061 · Cited by 70
“, 2013), caused oxidative damage (Butler et al., 2012; Pridgeon et al., 2007), and suppressed ATP production (Agorreta et al.”
BackgroundChege, P. M., & McColl, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00089 · Cited by 75
“DJ-1 and PINK1 have been shown to protect against oxidative stress (Junn et al., 2005; Pridgeon et al., 2007).”
BackgroundLiu, Y., Yan, J., Sun, C., Guo, L., Li, S., Zhang, L., Di, C., Gan, L., Wang, Y., Zhou, R., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.04.012 · Cited by 73
Fiesel, F. C., James, E. D., Hudec, R., & Springer, W. (2017) · Oncotarget · doi:10.18632/oncotarget.22287 · Cited by 67
“Interestingly, TRAP1 is directly phosphorylated by PINK1 [36] and overexpression of TRAP1 rescues PINK1, but not Parkin loss of function in Drosophila [37, 38] suggesting a role for TRAP1 downstream of PINK1, but parallel to or upstream of Parkin.”
BackgroundFitzgerald, J. C., & Plun‐Favreau, H. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06708.x · Cited by 66
Koh, H., Kim, H., Kim, M. J., Park, J., Lee, H.-J., & Chung, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337907 · Cited by 67
“3 The abbreviations used are: PD, Parkinson disease; Sir2, silent information regulator 2; FOXO, Forkhead box O; PINK1, PTEN-induced kinase 1; PTEN, phosphatase and tensin homolog; DA, dopaminergic; TRAP1, TNF receptor-associated protein 1; TH, tyrosine hydroxylase; SOD, superoxide dismutase; DL1, dorsolateral region…”
BackgroundInfluentialMatenia, D., Hempp, C., Timm, T., Eikhof, A., & Mandelkow, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262287 · Cited by 68
Wang, X., Feng, S., Wang, Y., Yuan, Y., Li, Z., Chen, N., Wang, Z., & Zhang, Y. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01039-w · Cited by 67
Mitochondrial Function and Parkinson’s Disease: From the Perspective of the Electron Transport Chain
Li, J., Lin, T.-Y., Chen, P., Guo, T.-N., Huang, S., Chen, C., Lin, C., & Chan, C. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.797833 · Cited by 78
Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
González-Hernández, T. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00140 · Cited by 65
PINK1 signalling in cancer biology
O’Flanagan, C. H., & O’Neill, C. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.006 · Cited by 69
“Overall, PINK1 maintains mitochondrial membrane potential, oxidative phosphorylation [69,118,119], complex I activity [69,117,120], reactive oxygen species (ROS) and Ca balance [54], regulates mitochondrial dynamics [58,67,70,121–124], protects from mitochondrial stress [43,58,69,96,125] and is a key regulator of mito…”
BackgroundBerthier, A., Navarro, S., Jiménez-Sáinz, J., Roglá, I., Ripoll, F., Cervera, J., & Pulido, R. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.05.016 · Cited by 71
“Moreover, siRNA silencing of PINK1 sensitizes the breast carcinoma MCF-7 cell line to mitochondrial-dependent apoptotic death stimuli, as described in other cell lines [14,29].”
BackgroundMitochondrial kinases in Parkinson’s disease: Converging insights from neurotoxin and genetic models
Dagda, R. K., Zhu, J., & Chu, C. T. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.06.001 · Cited by 70
“…against a variety of toxic insults including staurosporine, rotenone, proteasome inhibition, MPP+ and 6- OHDA (Dagda & Chu, unpublished data), while RNA interference (RNAi) knockdown of PINK1 has the opposite effect (Deng et al. 2005, Petit et al. 2005, Pridgeon et al. 2007, Haque et al. 2008).”
BackgroundAlpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice
Oliveras-Salvá, M., Macchi, F., Coessens, V., Deleersnijder, A., Gérard, M., Van der Perren, A., Van den Haute, C., & Baekelandt, V. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.032 · Cited by 62
“It has been shown in cells that overexpression of wild-type (WT) PINK1, but not of its PD-associated mutants, protects against apoptosis induced by proteasome inhibition, oxidative stress, and mitochondrial toxins (Deng et al., 2005; Haque et al., 2008; Klinkenberg et al., 2010; Plun-Favreau et al., 2007; Pridgeon et…”
Role of Mitochondrial Stress Response in Cancer Progression
Lee, Y. G., Park, D. H., & Chae, Y. C. (2022) · Cells · doi:10.3390/cells11050771 · Cited by 72
Xie, W., Wan, O. W., & Chung, K. K. K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.014 · Cited by 75
“TRAP1 is a mitochondrial chaperone and phosphorylation of TRAP1 by PINK1 suppresses the release of cytochrome c from the mitochondria when the cells are under various oxidative insults [38].”
BackgroundInfluentialNew insights into TRAP1 pathway.
Matassa, D. S., Amoroso, M. R., Maddalena, F., Landriscina, M., & Esposito, F. (2012) · PubMed Central · Cited by 62
Mitochondrial therapies for Parkinson's disease
Thomas, B., & Beal, M. F. (2010) · Movement Disorders · doi:10.1002/mds.22781 · Cited by 63
“Furthermore, PINK1, a mitochondrial kinase either due to loss of function or pathogenic mutations results in mitochondrial dysfunction and neurodegeneration due to abnormalities in mitochondrial morphology, bioenergetics, and by modulating cytochrome c release to block apoptosis in numerous in vivo and cell culture mo…”
BackgroundWilhelmus, M. M. M., Nijland, P. G., Drukarch, B., de Vries, H. E., & van Horssen, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.040 · Cited by 68
“further emphasized by the fact that PINK1 overexpression protects cells against hydrogen peroxide-induced apoptosis through interaction with the tumor necrosis factor-associated protein-1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 [83,91].”
BackgroundParkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress
Ciccone, S., Maiani, E., Bellusci, G., Diederich, M., & Gonfloni, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022388 · Cited by 62
“Several studies demonstrate that PINK1 is involved in mitochondrial metabolism and dynamics, protein degradation ubiquitin-mediated and oxidative stress [121,122].”
BackgroundGenetic models of Parkinson disease
Lim, K., & Ng, C.-H. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.005 · Cited by 71
“Interestingly, PINK1 also appears to phosphorylate the mitochondrial chaperone TRAP1 [128] as well as interacts with Hsp90 [129].”
BackgroundThe Roles of Kinases in Familial Parkinson's Disease
Cookson, M., Dauer, W. T., Dawson, T. M., Fon, E. A., Guo, M., & Shen, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3695-07.2007 · Cited by 71
“Mark R. Cookson,1 William Dauer,2 Ted Dawson,3 Edward A. Fon,4 Ming Guo,5 and Jie Shen6 1Cell Biology and Gene Expression Unit, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland 20892-3707, 2Departments of”
BackgroundInfluentialBlalock, E. M., Grondin, R., Chen, K.-C., Thibault, O., Thibault, V., Pandya, J. D., Dowling, A., Zhang, Z., Sullivan, P., Porter, N. M., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3956-09.2010 · Cited by 61
“These mitochondrial ARGs included Pink1, which plays an important role in protecting cells against oxidative stress and apoptosis (Pridgeon et al., 2007).”
BackgroundSzalárdy, L., Klivènyi, P., Zádori, D., Fülöp, F., Toldi, J., & Vécsei, L. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800167365 · Cited by 65
Liu, Y., Lear, T., Verma, M., Wang, K. Z. Q., Otero, P. A., McKelvey, A. C., Dunn, S. R., Steer, E. K., Bateman, N. W., Wu, C. C., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.131834 · Cited by 72
“its ability to suppress apoptosis (49), mitochondrial oxidative stress (12, 50, 51), and mitochondrial calcium”
BackgroundMolecular interaction between parkin and PINK1 in mammalian neuronal cells
Um, J. W., Stichel-Gunkel, C., Lübbert, H., Lee, G., & Chung, K. C. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.12.010 · Cited by 60
“PINK1 phosphorylates TNF receptorassociated protein 1, which leads to cell protection against oxidative stress-induced apoptosis (Pridgeon et al., 2007).”
BAG5 Protects against Mitochondrial Oxidative Damage through Regulating PINK1 Degradation
Wang, X., Guo, J., Fei, E., Mu, Y.-F., He, S., Che, X., Tan, J., Xia, K., Zhang, Z., Wang, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086276 · Cited by 62
“PINK1 protects against oxidative stress-induced apoptosis by directly phosphorylating its downstream effector, TNF receptorassociated protein 1 (TRAP1) [16]; and PINK1 modulates the levels of phosphorylated HtrA2, thereby contributing to an increased resistance of cells to mitochondrial stress [10,17].”
BackgroundAberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer
Zhang, B., Wang, J., Huang, Z., Wei, P., Liu, Y., Hao, J., Zhao, L., Zhang, F., Tu, Y., & Wei, T. (2015) · Oncotarget · doi:10.18632/oncotarget.6252 · Cited by 59
“TRAP1 interacts with cyclophilin D and regulates the mitochondrial permeability transition [18]; TRAP1 interacts with PINK1 and protects cells against oxidative stress-induced cell death [36]; TRAP1 interacts with the Ca2+-binding protein Sorcin and maintains its mitochondrial localization and stability [28].”
BackgroundKim, T., & Vemuganti, R. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17694186 · Cited by 63
“PINK1 colocalizes and phosphorylates TRAP1 (TNF receptor-associated protein 1; HSP75), which is a protein chaperone that protects mitochondria from oxidative stress.(115) In Drosophila, TRAP1 overexpression was shown to rescue PINK1 loss-of-function phenotypes.”
BackgroundPRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia
Ariës, I. M., Bodaar, K., Karim, S., Chonghaile, T. N., Hinze, L., Burns, M., Pfirrmann, M., Degar, J., Landrigan, J., Balbach, S. T., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180570 · Cited by 61
“TRAP1 is an HSP90 family chaperone that localizes to the mitochondrial inner membrane and inter-membrane space (Pridgeon et al., 2007).”
BackgroundManaa, W. E., Duplan, E., Goiran, T., Lauritzen, I., Vaillant-Beuchot, L., Lacas‐Gervais, S., Morais, V. A., You, H., Qi, L., Salazar, M., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1917129 · Cited by 59
Cross-talk between mitochondria and proteasome in Parkinson’s disease pathogenesis
Martins-Branco, D. A., Arduíno, D. M., Esteves, A. R., Silva, D. F. F., Cardoso, S. M., & Oliveira, C. R. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00017 · Cited by 73
“review that PINK1 protects cells against oxidative stress induced apoptosis by interacting with the mitochondrial chaperone tumor necrosis factor receptor-associated protein 1 (TRAP1)/heat shock protein 75 (Hsp75) (Pridgeon et al., 2007).”
Mutations that affect mitochondrial functions and their association with neurodegenerative diseases
Dhillon, V. S., & Fenech, M. F. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.09.001 · Cited by 63
“Some reports indicate its localization in inner mitochondrial membrane [147,149,150] whereas some”
BackgroundBiosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
Potashkin, J. A., Santiago, J. A., Ravina, B. M., Watts, A., & Leontovich, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043595 · Cited by 64
“The APD regulatory network connected 5 markers to the TNF and PTEN signaling pathways, which are involved in neurodegeneration (Figure 5B) [39].”
BackgroundNiemann, J., Johne, C., Schröder, S., Koch, F., Ibrahim, S. M., Schultz, J., Tiedge, M., & Baltrusch, S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.035 · Cited by 62
“In such circumstances, PINK1 protects mitochondria against oxidative stress-induced cell death by phosphorylating TRAP1 which in turn suppresses cytochrome c release from mitochondria and concomitant apoptosis [33].”
BackgroundTsai, P.-I., Course, M. M., Lovas, J. R., Hsieh, C.-H., Babić, M., Zinsmaier, K. E., & Wang, X. (2014) · Scientific Reports · doi:10.1038/srep06962 · Cited by 58
Structural Mechanisms of Mitochondrial Quality Control Mediated by PINK1 and Parkin
Trempe, J.-F., & Gehring, K. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168090 · Cited by 56
TRAP1 revisited: Novel localizations and functions of a ‘next-generation’ biomarker (Review)
AMOROSO, M. R., MATASSA, D. S., SISINNI, L., LETTINI, G., LANDRISCINA, M., & ESPOSITO, F. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2530 · Cited by 57
“Pridgeon et al (36) have indirectly linked TRAP1 to Parkinson's disease, demonstrating that PINK1, a major kinase whose mutations are involved in the development of autosomic recessive forms of PD, is a binding partner of TRAP1, phosphorylates it upon induction of oxidative stress, and that TRAP1 is required for PINK1…”
BackgroundUbiquitin phosphorylation in Parkinson’s disease: Implications for pathogenesis and treatment
Chin, L.-S., & Li, L. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-015-0049-6 · Cited by 58
“1) that PINK1 plays an intramitochondrial signaling role by phosphorylating TRAP1 [40] and potentially also other IMM/IMS-localized proteins, such as the complex I subunit NdufA10 [47] and the mitochondrial serine protease HtrA2 [48], to regulate activities of polarized mitochondria.”
BackgroundInfluentialSelf-citationPink1 protects cortical neurons from thapsigargin-induced oxidative stress and neuronal apoptosis
Li, L., & Hu, G.-K. (2015) · Bioscience Reports · doi:10.1042/bsr20140104 · Cited by 60
Self-citationCompartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones
Kang, B. H., & Altieri, D. C. (2009) · Oncogene · doi:10.1038/onc.2009.227 · Cited by 57
“[PubMed: 15930315] Pridgeon JW, Olzmann JA, Chin LS, Li L. PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1.”
BackgroundInfluentialKalmar, B., & Greensmith, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00251 · Cited by 57
“This effect is abolished in the absence of TRAP1, indicating that TRAP1 is essential for the protective response of mitochondria under conditions of oxidative stress (Pridgeon et al., 2007).”
BackgroundMitochondrial dynamics and neuronal fate in Parkinson's disease
Santos, D., & Cardoso, S. M. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.05.002 · Cited by 62
The Phosphorylation-Dependent Regulation of Mitochondrial Proteins in Stress Responses
Kanamaru, Y., Sekine, S., Ichijo, H., & Takeda, K. (2012) · Journal of Signal Transduction · doi:10.1155/2012/931215 · Cited by 56
“Although it has been reported that PINK1 can phosphorylate some mitochondrial proteins either directly or indirectly, including the chaperone TRAP1 [36] and the protease HtrA2 [37], the function of PINK1 was not fully clear.”
Lyakhovich, A., & LLeonart, M. E. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1716341 · Cited by 58
“Phosphorylation of TRAP1 by PTEN is responsible for the protection of ROS-mediated cell death [30].”
BackgroundMitochondrial TRAP1 regulates the unfolded protein response in the endoplasmic reticulum
Takemoto, K., Miyata, S., Takamura, H., Katayama, T., & Tohyama, M. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.02.015 · Cited by 60
“Mitochondrial TRAP1 undergoes phosphorylation by PINK1 and inhibits cytochrome c release from the mitochondria (Julia et al., 2007).”
Siegelin, M. D. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.045 · Cited by 59
Tickled PINK1: Mitochondrial homeostasis and autophagy in recessive Parkinsonism
Chu, C. T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.012 · Cited by 56
“PINK1 phosphorylates the mitochondrial heat shock protein 75 (also known as TNF receptorassociated protein 1) [73] and interacts with p38 MAPK in phosphorylating the mitochondrial protease HtrA2 [74].”
BackgroundTranscranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations
Hagenah, J., Becker, B., Brüggemann, N., Djarmati, A., Lohmann, K., Sprenger, A., Klein, C., & Seidel, G. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.142174 · Cited by 58
McKeon, J. E., Di, S., Li, L., & Chin, L. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1781-2 · Cited by 60
“The rabbit polyclonal anti-PINK1 antibody was generated and described in our previous study [41, 42].”
Self-citationSalazar, C., Ruiz‐Hincapie, P., & Ruíz, L. M. (2018) · Cells · doi:10.3390/cells7100154 · Cited by 55
“PINK1 supports mitochondrial membrane potential; oxidative phosphorylation [82–84] complex I activity [84]; ROS and Ca2+ balance [85]; protects from mitochondrial stress [62,63,83,86], regulates mitochondrial dynamics [61]; key regulator of mitophagy [87,88].”
BackgroundAngeles, D. C., Ho, P., Chua, L. L., Wang, C., Yap, Y. W., Ng, C., Zhou, Z., Lim, K., Wszołek, Z. K., Wang, H. Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu026 · Cited by 54
PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis
Akundi, R. S., Zhi, L., & Büeler, H. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.034 · Cited by 51
“…et al., 2009; Greene et al., 2005; Haque et al., 2008; Inden et al., 2006; Jiang et al., 2004; Kim et al., 2005b; Meulener et al., 2005; Park et al., 2005, 2006; Paterna et al., 2007; Pesah et al., 2004; Pridgeon et al., 2007; Saini et al., 2010; Thomas et al., 2011; Wood-Kaczmar et al., 2008).”
High expression of PINK1 promotes proliferation and chemoresistance of NSCLC
Zhang, R., Gu, J., Chen, J., Ni, J., Hung, J., Wang, Z., Zhang, X., Feng, J., & Ji, L. (2017) · Oncology Reports · doi:10.3892/or.2017.5486 · Cited by 52
PINK1: A Bridge between Mitochondria and Parkinson’s Disease
Gonçalves, F. B., & Morais, V. A. (2021) · Life · doi:10.3390/life11050371 · Cited by 64
“TRAP1 (TNF receptor associated protein 1/Heat shock protein 75) is an example, it plays a role in reducing reactive oxygen species (ROS) production and assisting protein folding [21,22].”
BackgroundEckermann, K. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8259-5 · Cited by 58
Agnihotri, S. K., Shen, R., Li, J., Gao, X., & Büeler, H. (2017) · The FASEB Journal · doi:10.1096/fj.201600960rr · Cited by 53
“In addition, PINK1—in pathways that are independent of Parkin— phosphorylates several mitochondrial proteins to protect cells against oxidative stress (45) and maintain mitochondrial complex I activity and respiration (46); however, the importance of recessive PD genes for hippocampal neu-”
BackgroundAutophagy and LRRK2 in the Aging Brain
Albanese, F., Novello, S., & Morari, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01352 · Cited by 55
Oshima, Y., Cartier, E. A., Boyman, L., Verhoeven, N. A., Polster, B. M., Huang, W., Kane, M. A., Lederer, W. J., & Karbowski, M. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202006043 · Cited by 54
Bonifati, V. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70008-7 · Cited by 60
“However, the PINK1 protein has a kinase domain and is targeted to the mitochondria, where it might exert neuroprotective effects (see [23] and references therein).”
BackgroundUQCRC1 Engages Cytochrome C for Neuronal Apoptotic Cell Death
Hung, Y.-C., Huang, K.-L., Chen, P., Li, J., Lu, S. H.-A., Chang, J., Lin, H., Lo, W.-C., Huang, S., Lee, T., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109729 · Cited by 47
Kubota, K., Inoue, K., Hashimoto, R., Kumamoto, N., Kosuga, A., Tatsumi, M., Kamijima, K., Kunugi, H., Iwata, N., Ozaki, N., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06099.x · Cited by 49
Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson’s disease
Chu, C. T. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.004 · Cited by 49
“PINK1 may also function to maintain high quality mitochondria through its ability to modulate the phosphorylation of complex I subunits, mitochondrial fission and transport proteins, mitochondrial chaperones and mitochondrial calcium transporters [39, 53, 60, 63, 69, 84].”
BackgroundChaperones—A New Class of Potential Therapeutic Targets in Alzheimer’s Disease
Batko, J., Antosz, K., Miśków, W., Pszczołowska, M., Walczak, K., & Leszek, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063401 · Cited by 51
“Due to this process, TRAP1 is unable to inhibit Cyt C release by CypD [74].”
BackgroundChen, B. B., Coon, T. A., Glasser, J. R., Zou, C., Ellis, B., Das, T., McKelvey, A. C., Rajbhandari, S., Lear, T., Kamga, C., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.048 · Cited by 48
“AUTHOR CONTRIBUTIONS R.K.M. was responsible for oversight of the studies; B.B.C. designed the study, performed experiments, analyzed the data, and wrote the manuscript; T.A.C., J.R.G., C.Z., B.E., T.D., C.K., A.C.M., S.R., T.L., and S.S. performed experiments; C.T.C., J.C., and C.L. assisted with animal experiments an…”
InfluentialPINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates
Matsui, H., Gavinio, R., Asano, T., Uemura, N., Ito, H., Taniguchi, Y., Kobayashi, Y., Maki, T., Shen, J., Takeda, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt095 · Cited by 47
“First, we confirmed the expression, in Parkin-deficient MEF, of exogenous Parkin, PINK1 and two PINK1 mutants; L347P PINK1, a disease-related kinase-inactive, and D362A; D384A PINK1, a kinase-dead mutant containing mutations in catalytically important residues that have been shown individually to inactivate PINK1 kina…”
Wang, T. S., Coppens, I., Saorin, A., Brady, N. R., & Hamacher‐Brady, A. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.05.014 · Cited by 54
“Accessibility of antigenic epitopes inside OMM-enclosed mitochondrial compartments was assessed using antibodies against the mitochondrial chaperone TRAP1 (Novus Biologicals), which resides in inner mitochondrial compartments (Pridgeon et al., 2007).”
BackgroundMethodInfluentialFunctions and characteristics of PINK1 and Parkin in cancer
Matsuda, S., Nakanishi, A., Minami, A., Wada, Y., & Kitagishi, Y. (2015) · Frontiers in bioscience · doi:10.2741/4321 · Cited by 52
Mitochondrial quality control pathways: PINK1 acts as a gatekeeper
Leites, E. P., & Morais, V. A. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.096 · Cited by 50
Feng, S., Wang, Z., Yuan, Y., Sun, H., Chen, N., & Zhang, Y. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14699 · Cited by 47
Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease
Magnusen, A. F., Hatton, S. L., Rani, R., & Pandey, M. K. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.636139 · Cited by 47
Hsp90 Inhibitors Disrupt Mitochondrial Homeostasis in Cancer Cells
Neckers, L., Kern, A., & Tsutsumi, S. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.002 · Cited by 47
Targeting Mitochondria for Neuroprotection in Parkinson's Disease
Schapira, A. H. V. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4419 · Cited by 48
The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation
Cannino, G., Urbani, A., Gaspari, M., Varano, M., Negro, A., Filippi, A., Ciscato, F., Masgras, I., Gerle, C., Tibaldi, E. V., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01020-0 · Cited by 50
Serviddio, G., Davide Romano, A., Cassano, T., Bellanti, F., Altomare, E., & Vendemiale, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796904740 · Cited by 46
“Pridgeon and colleagues found that PINK1 phosphorylates mitochondrial heat shock protein TNFR-associated protein 1 (TRAP1) and that the protective activity of PINK1 against oxidative stress is dependent on TRAP1 phosphorylation [281].”
BackgroundHsp90 regulation of mitochondrial protein folding: from organelle integrity to cellular homeostasis
Altieri, D. C. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1177-0 · Cited by 46
“localization studies have confirmed that TRAP-1 is indeed a mitochondrial-compartmentalized chaperone [12, 20], predominantly localized to the matrix [20], with a smaller fraction present in the intermembrane space [21].”
InfluentialSung, N., Lee, J., Kim, J., Chang, C., Joachimiak, A., Lee, S., & Tsai, F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516167113 · Cited by 50
Parkinson's disease and glucose metabolism impairment
Chen, L., Wang, C., Qin, L., & Zhang, H. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00467-8 · Cited by 57
Lin, W., Wadlington, N. L., Chen, L., Zhuang, X., Brorson, J. R., & Kang, U. J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2286-13.2014 · Cited by 45
“PTEN-induced putative kinase-1 (PINK1) is a nuclear-encoded serine/threonine kinase that localizes to mitochondria and cytosol (Lin and Kang, 2008) and promotes cell survival through distinct functions in both cellular compartments (Pridgeon et al., 2007; Haque et al., 2008).”
BackgroundQu, M., Zhou, Z., Chen, C., Li, M., Pei, L., Yang, J., Wang, Y., Li, L., Liu, C., Zhang, G., et al. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.09.009 · Cited by 47
Self-citationBalance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease
Burbulla, L. F., Krebiehl, G., & Krüger, R. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02354.x · Cited by 46
Yung, C., Di, S., Li, L., & Chin, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9537-z · Cited by 49
“4′,6-diamidino-2-phenylindole (DAPI, Life Technologies) as described [43].”
Self-citationWang, K. Z. Q., Steer, E., Otero, P. A., Bateman, N. W., Cheng, M. H., Scott, A. L., Wu, C., Bahar, I., Shih, Y.-T., Hsueh, Y.-P., et al. (2018) · eneuro · doi:10.1523/eneuro.0466-18.2018 · Cited by 45
“Processed PINK1 interacts with the D1 domain of VCP to regulate neurite extension Mitochondrially localized pools of PINK1 are required for many of its regulatory effects on mitochondrial homeostasis (Pridgeon et al., 2007; Matsuda et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010; Zhang et al., 2013; Mora…”
BackgroundInfluentialParkin mitochondria in the autophagosome
McBride, H. M. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200810184 · Cited by 45
“Similarly, peroxide-induced stress led to a Pink1-dependent phosphorylation of Trap1/Hsp75, whose chaperone activity appears to assist in the refolding of damaged proteins and reduction of mitochondrial ROS ( Pridgeon et al., 2007 ).”
BackgroundTRAP1 Chaperones the Metabolic Switch in Cancer
Wengert, L. A., Backe, S. J., Bourboulia, D., Mollapour, M., & Woodford, M. R. (2022) · Biomolecules · doi:10.3390/biom12060786 · Cited by 45
“Modification Enzyme Residue Paralog Impact on TRAP1 Reference S-Nitrosylation GSNOR Cys501 Thr495 Decreased activity,proteasomal degradation [98] Phosphorylation ERK1/2 Ser511 Ser505 N/A [10] Phosphorylation ERK1/2 Ser568 Glu562 Increased SDH inhibition [10] S/T Phosphorylation PINK1 N/A N/A N/A [5] Y Phosphorylation…”
BackgroundInfluentialGenetic basis of Parkinson disease
Xiromerisiou, G., Dardiotis, E., Tsimourtou, V., Kountra, P., Paterakis, K. N., Kapsalaki, E. Z., Fountas, K. N., & Hadjigeorgiou, G. M. (2009) · Neurosurgical FOCUS · doi:10.3171/2009.10.focus09220 · Cited by 55
Chen, S., Lin, T., Yang, D., Lee, S.-Y., Shaw, F.-Z., Liou, C., & Chuang, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.045 · Cited by 45
PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration
Chen, Y., Deng, J., Wang, P., Yang, M., Chen, X., Zhu, L., Liu, J., Lu, B., Shen, Y., Fushimi, K., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw310 · Cited by 48
“In contrast to the neuroprotective activities of PINK1 and Parkin demonstrated in previous studies (30,37), our results suggest that”
BackgroundResultFurlong, R. M., Lindsay, A. J., Anderson, K. E., Hawkins, P. T., Sullivan, A. M., & O’Neill, C. (2019) · Journal of Cell Science · doi:10.1242/jcs.233221 · Cited by 47
TRAP1 in Oxidative Stress and Neurodegeneration
Ramos Rego, I., Santos Cruz, B., Ambrósio, A. F., & Alves, C. H. (2021) · Antioxidants · doi:10.3390/antiox10111829 · Cited by 44
“PTEN-induced kinase 1 (PINK1) depletion leads to CytC release, which correlates with the reduction in TRAP1 phosphorylation by PINK1 [64].”
BackgroundInfluentialGenetic Mouse Models of Neurodegenerative Diseases
Trancikova, A. K., Ramonet, D., & Moore, D. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00012-1 · Cited by 54
“PINK1 mutations (G309D, L347P, and W437X) impair TRAP1 phosphorylation and PINK1-mediated protection.(189) Interaction of PINK1 with Hsp90 regulates PINK1 protein stability since Hsp90 inhibitors markedly reduce PINK1 levels.”
BackgroundNeuronal responses to stress and injury in C. elegans
Kim, K. W., & Jin, Y. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.005 · Cited by 44
“Mutations in PINK1 are associated with early onset of familial Parkinson’s disease [38], and PINK1 has been shown to protect against cell death induced by oxidative stress [39,40].”
Background
Metadata
- Authors
- Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L.
- Affiliations
- Emory University (US)
- Corresponding author
- Chin, Lih-Shen
- Li, Lian
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-06-19
- Volume
- 5
- Issue
- 7
- Pages
- e172
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC1892574
- OpenAlex
- W2055538245
- Cited by
- 596
- References
- 44
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 29 · 2020: 27 · 2019: 14 · 2018: 25 · 2017: 30 · 2016: 21 · 2015: 36 · 2014: 39 · 2013: 39 · 2012: 45
- FWCI
- 42.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (AG021489, R01AG021489)
- National Institute of Neurological Disorders and Stroke (F31NS054597, NS-047199, R01NS047199, NS050650, R01NS050650)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, TRAP1, Parkinson's disease, oxidative stress, mitochondrial chaperone, protein phosphorylation, cytochrome c release, apoptosis, PINK1 mutations, neurodegeneration
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Base Sequence, HeLa Cells, Humans, Mitochondria, Phosphorylation, Protein Binding, Protein Kinases, Recombinant Proteins, Substrate Specificity, Transfection, PC12 Cells, Apoptosis, Point Mutation, Oxidative Stress, HSP90 Heat-Shock Proteins, Parkinsonian Disorders, RNA, Small Interfering, Cytochromes c, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.